The store will not work correctly when cookies are disabled.
5-Difluoromethyl-1-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-1H-pyrimidine-2,4-dione
ID: ALA2368800
Cas Number: 101527-46-2
PubChem CID: 130510
Max Phase: Preclinical
Molecular Formula: C10H12F2N2O5
Molecular Weight: 278.21
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1C(F)F
Standard InChI: InChI=1S/C10H12F2N2O5/c11-8(12)4-2-14(10(18)13-9(4)17)7-1-5(16)6(3-15)19-7/h2,5-8,15-16H,1,3H2,(H,13,17,18)/t5-,6+,7+/m0/s1
Standard InChI Key: YATQDPXPMDMPID-RRKCRQDMSA-N
Molfile:
RDKit 2D
19 20 0 0 1 0 0 0 0 0999 V2000
2.0482 -1.6716 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7127 -2.4253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1976 -3.0927 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.3536 -2.2528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5633 -1.0041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0181 -3.0065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8687 -1.5853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8183 -0.2195 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.7383 -1.0041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1508 0.2654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1741 -2.1665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4834 -0.2195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8922 -2.5115 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.5030 -3.6739 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.6591 -2.8340 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
4.5097 -1.4129 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-0.3012 0.0354 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.1508 1.0904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4364 1.5029 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 7 2 0
5 1 1 1
6 4 1 0
7 1 1 0
8 5 1 0
5 9 1 0
10 8 1 0
11 4 1 0
12 9 1 0
13 2 2 0
14 6 2 0
15 11 1 0
16 11 1 0
12 17 1 6
10 18 1 1
19 18 1 0
3 6 1 0
10 12 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 278.21 | Molecular Weight (Monoisotopic): 278.0714 | AlogP: -0.89 | #Rotatable Bonds: 3 |
Polar Surface Area: 104.55 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.99 | CX Basic pKa: ┄ | CX LogP: -1.24 | CX LogD: -1.25 |
Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.67 | Np Likeness Score: 0.42 |
References
1. Matulic-Adamic J, Takahashi K, Chou TC, Gadler H, Price RW, Reddy AR, Kalman TI, Watanabe KA.. (1988) Nucleosides. 150. Synthesis and some biological properties of 5-monofluoromethyl, 5-difluoromethyl, and 5-trifluoromethyl derivatives of 2'-deoxyuridine and 2'-deoxy-2'-fluoro-beta-D-arabinofuranosyluracil., 31 (8): [PMID:2840503] [10.1021/jm00403a026] |